Common joint supplement linked to faster memory loss in Alzheimer’s patients, new study finds

People with Alzheimer’s disease who took the common supplement glucosamine were 25% more likely to die within five years than those who didn’t

People with Alzheimer’s disease who took the common supplement glucosamine were 25% more likely to die within five years than those who didn’t

People with Alzheimer’s disease who took the common supplement glucosamine were 25% more likely to die within five years than those who didn’t